The chance of completely removing skin cancer depends on the cancer type, how deeply it grows, and whether the surgeon removes all cancer cells. These factors also affect the risk of the cancer returning after treatment.
1. How Cancer Type Affects Treatment Success
Different skin cancers behave in different ways, so doctors choose treatment based on the diagnosis.
Basal cell carcinoma (BCC): This is the most common type of skin cancer. It usually grows slowly and rarely spreads to distant parts of the body. Complete removal often provides excellent results, although some tumors can return if they are aggressive or incompletely removed.
Squamous cell carcinoma (SCC): This cancer can grow deeper and may spread to nearby lymph nodes or other organs. Larger, deeper, recurrent, or poorly differentiated tumors have a higher risk of recurrence and spread.
Melanoma: This cancer develops from pigment-producing cells in the skin. Its risk depends strongly on tumor thickness and other features. Early melanoma can often be treated successfully with surgery, while thicker or more advanced melanoma may require additional treatment.
2. Why Tumor Depth Matters
Tumor depth shows how far cancer has grown into the skin and nearby tissues.
- Shallow tumors: These may be easier to remove completely, especially when they have low-risk features.
- Deeper tumors: These may extend into fat, muscle, nerves, or other structures, making complete removal more complex.
- Melanoma thickness: Doctors measure melanoma thickness, called Breslow thickness. Greater thickness generally increases the risk of spread and affects decisions about surgery and further testing.
- Tumors involving nerves or deeper structures: These may need more extensive surgery or specialist treatment.
A tumor's depth is only one factor. Its location, cell features, and whether it has spread also matter.
3. What Clear Surgical Margins Mean
A surgical margin is the edge of the tissue removed during surgery. A pathologist examines the tissue to check whether cancer cells reach these edges.
Clear margins: No cancer cells are found at the examined edges. This suggests the tumor has been completely removed from the sampled tissue and usually lowers the risk of local recurrence.
Positive margins: Cancer cells reach an examined edge. Some cancer may remain, so the surgeon may recommend another excision or an appropriate additional treatment.
Close margins: Cancer is near the edge but does not reach it. The next step depends on the cancer type, tumor risk, location, and applicable treatment guidelines.
Clear margins reduce risk, but they cannot guarantee that cancer will never return. Some tumors can recur even after apparently complete removal.
4. How Mohs Surgery Can Help
Mohs surgery removes the tumor in thin layers and examines the tissue during the procedure. The surgeon continues removing tissue where cancer remains until the examined margins are clear.
It may be useful for selected basal cell and squamous cell cancers, particularly those on the face, those with unclear borders, or those that have returned after earlier treatment.
Standard excision is also effective for many skin cancers. The appropriate technique depends on the tumor's risk and location.
5. What Happens If Cancer Is Not Completely Removed?
If pathology shows positive margins, the doctor may recommend further surgery. Some patients may need a different treatment based on the cancer type and their medical condition.
For melanoma, doctors may recommend a wider excision based on the tumor's thickness and other findings. Additional tests or treatments may be needed for higher-risk disease.
Patients should ask their surgeon to explain the pathology report, margin status, and whether any further treatment is needed.
6. How Patients Can Reduce the Risk of Recurrence
- Attend all recommended follow-up appointments.
- Check the skin regularly for new or changing spots.
- Protect the skin from excessive ultraviolet exposure.
- Report a new lump, changing mole, non-healing sore, or growth near the surgical scar.
- Follow the specialist's plan for further treatment if margins are involved or the cancer has high-risk features.
